Chemotherapy News and Research

RSS

Chemotherapy, in its most general sense, is the treatment of disease by chemicals especially by killing micro-organisms or cancerous cells. In popular usage, it refers to antineoplastic drugs used to treat cancer or the combination of these drugs into a cytotoxic standardized treatment regimen.

Cell survival protein could protect the kidneys from 'bystander' damage during cancer therapy

Australian researchers have identified a protein that could protect the kidneys from 'bystander' damage caused by cancer therapies.

From Walter and Eliza Hall Institute of Medical Research (WEHI) 26 Nov 2020

Study may lead to new strategies that minimize inflammatory reactions after cell transplants

The term leukaemia is used to describe a group of malignant diseases of the haematopoietic system, in which precursors of the white blood cells (leucocytes) proliferate uncontrollably.

20 Nov 2020

Novel DNA-based nanogel for targeted delivery of chemotherapeutics

Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells.

19 Nov 2020

Study shows CRISPR/Cas9 system can effectively treat metastatic cancers

Researchers have shown that the advanced CRISPR/Cas9 system is extremely effective in curing metastatic cancers.

19 Nov 2020

Light-activated liposomes could help deliver CRISPR gene therapy

Light-activated liposomes could help to deliver CRISPR gene therapy - and the method could prove safer and more direct than current methods.

From The University of New South Wales (UNSW) 16 Nov 2020

Study shows 1 in 8 cancer patients had inherited cancer-related gene mutation

Genetic testing can uncover inherited genetic mutations, and could individualize cancer therapies, improve survival, manage cancer in loved ones and push the boundaries of precision medicine.

3 Nov 2020

'Training’ the innate immunity may improve the success of immunotherapy

Immunotherapies, such as checkpoint inhibitor drugs, have made worlds of difference for the treatment of cancer. Most clinicians and scientists understand these drugs to act on what's known as the adaptive immune system, the T cells and B cells that respond to specific threats to the body.

30 Oct 2020

Dual-chip system for monitoring heart toxicity from breast cancer drugs

Breast cancer is the most commonly occurring cancer for women around the world, and much effort has been spent in the development of therapies to treat this disease.

27 Oct 2020

Researchers identify a promising target for treating chemo-resistant cancer cells

As medical professionals and scientists work to design new therapies for cancer, they come across a range of difficulties.

26 Oct 2020

Rutgers researchers discover gene markers linked to metastatic prostate cancer

Rutgers researchers have discovered human gene markers that work together to cause metastatic prostate cancer - cancer that spreads beyond the prostate.

From Rutgers University 20 Oct 2020

Cell nucleus may enable the cells to evade crowded environments

Like people, cells in the human body protect their personal space. They seem to know how much space they need, and if it gets too tight, most cells prefer to break free.

20 Oct 2020

New nanoparticles can destroy drug-resistant cancer cells

Multidrug resistance, or MDR, is a process in which tumors become impervious to numerous drugs and is a major cause of failure in cancer chemotherapy.

19 Oct 2020

Treatment using immune system T cells preserves vision of mice with retinoblastoma

A treatment that uses immune system T cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with tissue from a human eye cancer known as retinoblastoma.

13 Oct 2020

Immune cell biomarker may help identify patients at risk for graft-versus-host disease

A recent report published in Science Translational Medicine by MUSC Hollings Cancer Center investigator Sophie Paczesny, M.D., Ph.D., sheds light on immune cell biomarkers that may reveal which patients are most at risk for graft-versus-host disease (GVHD), a life-threatening condition that can arise after hematopoietic stem cell transplantation (HSCT) for treatment of liquid cancers such as leukemia.

8 Oct 2020

New drug shows promise in the treatment of neuroblastoma

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine.

7 Oct 2020

Genetic test identifies patients with invasive lobular carcinoma at high risk of recurrence

New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.

1 Oct 2020

Chemotherapy News and Research

Cell survival protein could protect the kidneys from 'bystander' damage during cancer therapy

Study may lead to new strategies that minimize inflammatory reactions after cell transplants

Novel DNA-based nanogel for targeted delivery of chemotherapeutics

Study shows CRISPR/Cas9 system can effectively treat metastatic cancers

Light-activated liposomes could help deliver CRISPR gene therapy

Study shows 1 in 8 cancer patients had inherited cancer-related gene mutation

'Training’ the innate immunity may improve the success of immunotherapy

Dual-chip system for monitoring heart toxicity from breast cancer drugs

Researchers identify a promising target for treating chemo-resistant cancer cells

Rutgers researchers discover gene markers linked to metastatic prostate cancer

Cell nucleus may enable the cells to evade crowded environments

New nanoparticles can destroy drug-resistant cancer cells

Treatment using immune system T cells preserves vision of mice with retinoblastoma

Immune cell biomarker may help identify patients at risk for graft-versus-host disease

New drug shows promise in the treatment of neuroblastoma

Genetic test identifies patients with invasive lobular carcinoma at high risk of recurrence

Researchers identify key molecules that contribute to radioresistance in glioblastoma

Scientists identify a novel approach to regulate cell plasticity

New precision drug targeting cancer's ability to repair DNA shows promise

T-cell-based vaccine strategy provides broader protection against influenza

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics